Felix Hammann

14PUBLICATIONS
24CO-AUTHORS
Biologically active moleculesPharmacogenomicsInfectious diseasesHost-parasite interactionsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 12, 2026
Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances.

|Apr 03, 2026
Improving Population Pharmacokinetic Modelling with Artificial Patients using Generative Artificial Intelligence.

Verena Schöning, Felix Hammann

|Oct 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive Staphylococcus aureus Infections: A Prospective Cohort Study.

Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis

|Jul 01, 2024
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection.

Laura Hermann, Verena Schöning, Sarah Dräger

|Apr 10, 2024
Pharmacokinetics and Pharmacodynamics of Inhaled Nicotine Salt and Free-Base Using an E-cigarette: A Randomized Crossover Study.

Samuel E Christen, Laura Hermann, Elias Bekka

|Feb 22, 2023
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings.

Carlos Chaccour, Aina Casellas, Felix Hammann

Pageof 3

Frequent Collaborators

6 joint publications

Verena Schöning

2 joint publications

Evangelia Liakoni

2 joint publications

Katharina Elisabeth Grafinger

2 joint publications

Urs Duthaler